Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | PREP | P48147 | 4/20 | 0.42 |
| ▸ | GYS1 | P13807 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10340335 | 1.00 | ACE (0.44) | ACEPREPGYS1L3MBTL1CA2 | |
| SCHEMBL10739647 | 0.84 | PIK3CD (0.46) | L3MBTL1ALDH1A1PIK3CDHPGDLMNA | |
| SCHEMBL29053621 | 0.82 | MEN1 (0.46) | ACEALDH1A1HPGDLMNASMN1; SMN2 | |
| SCHEMBL11202153 | 0.79 | LMNA (0.40) | ACEPREPALDH1A1MMP2MMP9 | |
| SCHEMBL11197968 | 0.79 | PREP (0.49) | ACEPREPL3MBTL1ALDH1A1LMNA | |
| SCHEMBL11202154 | 0.79 | LMNA (0.40) | ACEPREPALDH1A1MMP2MMP9 | |
| SCHEMBL10470684 | 0.79 | HTR1A (0.46) | CA2ALDH1A1HPGDTSHR | |
| SCHEMBL14397441 | 0.77 | ACE (0.45) | ACEPREPGYS1L3MBTL1 | |
| SCHEMBL3200492 | 0.77 | FFAR2 (0.46) | GYS1MMP2MMP9 | |
| SCHEMBL774094 | 0.77 | FFAR2 (0.46) | GYS1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703750-B2 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2014-04-22 | — | — | US | disclosed |
| US-20100317519-A1 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2010-12-16 | — | — | US | disclosed |
| US-20070173459-A1 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2007-07-26 | — | — | US | disclosed |
| EP-1720408-A1 | MIXTURES AND METHODS FOR THE INDUCTION OF RESISTANCE IN PLANTS | ISAGRO S.p.A. (IT) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005094580-A1 | MIXTURES AND METHODS FOR THE INDUCTION OF RESISTANCE IN PLANTS | ISAGRO S.P.A. (IT) | 2005-10-13 | — | — | WO | disclosed |
| US-4745124-A | THIO/ESTER PEPTIDES | UNIVERSITY OF MIAMI (US) | 1988-05-17 | — | — | US | disclosed |
| EP-0036713-A2 | Angiotensin converting enzyme inhibitors | UNIVERSITY OF MIAMI (US) | 1981-09-30 | — | — | EP | disclosed |
| US-4075219-A | Epimerization process | ELI LILLY AND COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173459-A1 | Mixtures and methods for the induction of resistance in plants | SLC11A2, MYD88, ME2 | ACE 1249/4885PREP 2070/4885GYS1 2381/4885 |
| US-20100317519-A1 | Mixtures and methods for the induction of resistance in plants | SLC11A2, MYD88, ME2 | ACE 1249/4885PREP 2070/4885GYS1 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.